Dipyrone for the acute treatment of Dialysis Headache
Phase 2
- Conditions
- HeadacheC23.888.592.612
- Registration Number
- RBR-3sdgfyy
- Lead Sponsor
- Pós Graduação em Neuropsiquiatria e Ciências do Comportamento - Universidade Federal de Pernambuco
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Patients of both genders; aged 18 years or over; on hemodialysis treatment for chronic renal failure; diagnosed with dialysis headache according to the criteria of the International Classification of Headache Disorders (ICHD-3); who experience this headache during dialysis
Exclusion Criteria
Patients who have a known diagnosis of Acute Chronic Renal Failure; patients who are allergic to dipyrone
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of patients who were free of pain after 02 hours of administration of the intervention.
- Secondary Outcome Measures
Name Time Method Percentage of patients who improved their pain after 02 hours (decrease in pain from moderate to severe (5 to 7 points) at baseline to mild or no pain (0 to 4 points) after 2 hours of administration of the intervention.;Time to obtain significant pain relief and complete improvement;Percentage of patients with sustained headache relief – patients who were pain-free after 2 hours of the intervention and who had no recurrence or need for rescue medication for pain in the first 24 hours after the intervention;Global evaluation of the patient in relation to the intervention.;Incidence of adverse effects